Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts

Catheterization and Cardiovascular Interventions

Volumn 66, Issue 4, 2005, Pages 507-511

  Lee, Michael S ^a   Shah, Atman P ^b   Aragon, Joseph ^a   Jamali, Aamer ^a   Dohad, Suhail ^a   Kar, Saibal ^a   Makkar, Raj R ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Drug eluting stent; Percutaneous coronary intervention; Saphenous vein graft

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; METAL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DEVICE; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; STENT; TREATMENT OUTCOME;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METALS; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS; TREATMENT OUTCOME;

EID: 28844482806     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20498     Document Type: Article

References (27)

1. Fitzgibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol 1991;17:1075-1080.
2. Fitzgibbon GM, Kafka HP, Leach AJ, Keon KW, Hooper GD, Burton JR. Coronary artery bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
3. de Feyter PJ. Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem. Circulation 2003;107:2284-2286.
4. Baim DS. Percutaneous treatment of saphenous vein graft disease. J Am Coll Cardiol 2003;42:1370-1372.
5. Guthaner DF, Robert EW, Alderman EL, Wexler L. Long-term serial angiographic studies after coronary artery bypass surgery. Circulation 1979;60:250-259.
6. Bourassa MG, Engalbert M, Campeau L, Lesperance J. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol 1984;53:102C-107C.
7. Virmani R, Atkinson JB, Forman MB. Aorto-coronary saphenous vein bypass grafts. Cardiovasc Clin 1988;18:41-59.
8. Morrison DS, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience for post-CABG patients. J Am Coll Cardiol 2002;40:1951-1954.
9. Loop FD. A 20-year experience in coronary artery reoperations. Eur Heart J 1989;10(Suppl M):78-84.
10. Foster ED, Fisher LD, Kaiser GC, et al. Comparison of operative mortality and morbidity for initial and repeat coronary artery bypass grafting: the Coronary Artery Surgery Study Registry experience. Ann Thorac Surg 1984;38:563-570.
11. Lytle BW, Loop FD, Cosgrove DM, et al. Fifteen hundred coronary reoperations: results and determinants of early and late survival. J Thorac Cardiovasc Surg 1987;93:847-859.
12. Savage MP, Douglas JS Jr, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts: Saphenous Vein De Novo Trial investigators. N Engl J Med 1997;337:740-747.
13. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001;38:659-665.
14. Lefkovits J, Holmes DR, Califf RM, et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation 1995;92:734-740.
15. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400-2405.
16. Ellis SG, Brener SJ, DeLuca S, et al. Late myocardial ischemic events after saphenous vein graft intervention-importance of initially "nonsignificant" vein graft lesions. Am J Cardiol 1997;79:1460-464.
17. Laham RJ, Carrozza JP, Berger C, Cohen DJ, Kuntz RE, Baim DS. Long-term (4-6 year) outcome after Palmaz-Schatz stenting-paucity of late stent-related problems. J Am Coll Cardiol 1996;28:820-826.
18. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
19. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
20. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
21. Strauss BH, Serruys PW, Bertrand ME, et al. Quantitative angiographic follow-up of the coronary wallstent in native vessels and bypass grafts (European experience, March 1986 to March 1990). Am J Cardiol 1992;69:475-481.
22. Safian RD, Kaplan B, Schreiber T, et al. Final results of the randomized Wallstent endoprosthesis in saphenous vein graft trial (WINS). J Am Coll Cardiol 1999;33:37A.
23. de Jaegere PP, van Domburg RT, de Feyter PM, et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996;28:89-96.
24. Strumpf RK, Mehta SS, Ponder R, Heuser RR. Palmaz-Schatz stent implantation in stenosed saphenous vein grafts: clinical and angiographic follow-up. Am Heart J 1992;123:1329-1336.
25. Carrozza JP, Kuntz RE, Levine MJ, et al. Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992;20:328-337.
26. Kuntz RE, Safian RD, Carrozza JP, et al. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation 1992;86:1827-1835.
27. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436.